Article

Association Between FSIP2 Mutation and an Improved Prognosis in Patients With Skin Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors

2020-08-07

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) have been remarkably successful in skin cutaneous melanoma (SKCM), however the response to treatment varies greatly among different patients. Considering that the efficacy of ICI treatment is affected by many factors, we selected the Fibrosheath interacting protein 2 (FSIP2) gene and systematically analyzed its potential as a predictor of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 84c2c06a-ba8d-52ef-9cd6-41af84f861ca
DOI: 10.21203/rs.3.rs-52494/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association Between FSIP2 Mutation and an Improved Prognosis in Patients With Skin Cutaneous Melanoma Treated With Immune Checkpoint InhibitorsDOI 10.21203/rs.3.rs-52494/v1Read

Identification and validation of three risk models in skin melanoma based on bioinformatics analysisSemantic proximity Read

Immuno-Genomic Landscape of Cutaneous Melanoma Identifies a Prognostic and Immunotherapeutically Relevant Gene SignatureSemantic proximity Read

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanomaSemantic proximity Read

Prognostic value and immune status of AIM2 in skin cutaneous melanomaSemantic proximity Read

Expression Pattern and Clinical Significance of E2F Transcription Factors in Skin Cutaneous MelanomaSemantic proximity Read

AIM2 is an potential biomarker associated with the Immune-active Tumor Microenvironment Remodeling and PANoptosis in skin cutaneous melanomaSemantic proximity Read

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.Semantic proximity Read

Identification of Biomarkers with Therapeutic And prognostic Value in Skin Cutaneous MelanomaSemantic proximity Read

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.Semantic proximity Read

IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomasSemantic proximity Read

Illuminating HLA-DPA1 and HSH2D as Potential Prognostic Biomarkers by Weighted Gene Co-Expression Network Analysis for NRAS-Mutant Skin Cutaneous MelanomaSemantic proximity Read

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblasts Signature for Predicting Prognosis and Immunotherapeutic Responses in Skin Cutaneous MelanomaSemantic proximity Read